BackArtiva Biotherapeutics Overview

Artiva Biotherapeutics Long Term Debt

Track Artiva Biotherapeutics's long-term debt ($6.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$6.55M
31.64% YoYΔ $-3.03M vs prior year quarter

Peer average / median

Loading

Artiva Biotherapeutics Long Term Debt History

Loading

Artiva Biotherapeutics vs. peers: Long Term Debt Comparison

Loading

Artiva Biotherapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Artiva Biotherapeutics (ARTV) FAQ

Artiva Biotherapeutics (ARTV) currently reports a long-term debt of $6.6M as of June 2026. That compares with $9.6M in the prior-year period — down 31.6% year over year. Use the charts on this page to explore Artiva Biotherapeutics's long-term debt history and peer comparisons.

Artiva Biotherapeutics's long-term debt decreased from $9.6M to $6.6M — a 31.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Artiva Biotherapeutics reported $6.6M in long-term debt as of June 2026. That compares with $9.6M in the prior-year period — down 31.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $6.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Artiva Biotherapeutics, and consider following ARTV for alerts when major investors trade the stock.